161 related articles for article (PubMed ID: 26645485)
1. Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: Role of Rac and PI3K.
Molnár J; Fazakas C; Haskó J; Sipos O; Nagy K; Nyúl-Tóth Á; Farkas AE; Végh AG; Váró G; Galajda P; Krizbai IA; Wilhelm I
Cell Adh Migr; 2016 May; 10(3):269-81. PubMed ID: 26645485
[TBL] [Abstract][Full Text] [Related]
2. Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases.
Fazakas C; Wilhelm I; Nagyoszi P; Farkas AE; Haskó J; Molnár J; Bauer H; Bauer HC; Ayaydin F; Dung NT; Siklós L; Krizbai IA
PLoS One; 2011; 6(6):e20758. PubMed ID: 21674054
[TBL] [Abstract][Full Text] [Related]
3. Involvement of PI3K and ROCK signaling pathways in migration of bone marrow-derived mesenchymal stem cells through human brain microvascular endothelial cell monolayers.
Lin MN; Shang DS; Sun W; Li B; Xu X; Fang WG; Zhao WD; Cao L; Chen YH
Brain Res; 2013 Jun; 1513():1-8. PubMed ID: 23548598
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Malignant Breast Cancer Cell MDA-MB-231 Transmigration Across Brain and Lung Microvascular Endothelium.
Fan J; Fu BM
Ann Biomed Eng; 2016 Jul; 44(7):2189-201. PubMed ID: 26603751
[TBL] [Abstract][Full Text] [Related]
5. Paracellular and transcellular migration of metastatic cells through the cerebral endothelium.
Herman H; Fazakas C; Haskó J; Molnár K; Mészáros Á; Nyúl-Tóth Á; Szabó G; Erdélyi F; Ardelean A; Hermenean A; Krizbai IA; Wilhelm I
J Cell Mol Med; 2019 Apr; 23(4):2619-2631. PubMed ID: 30712288
[TBL] [Abstract][Full Text] [Related]
6. PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases In Vitro and In Vivo.
Niessner H; Schmitz J; Tabatabai G; Schmid AM; Calaminus C; Sinnberg T; Weide B; Eigentler TK; Garbe C; Schittek B; Quintanilla-Fend L; Bender B; Mai M; Praetorius C; Beissert S; Schackert G; Muders MH; Meinhardt M; Baretton GB; Dummer R; Flaherty K; Pichler BJ; Kulms D; Westphal D; Meier F
Clin Cancer Res; 2016 Dec; 22(23):5818-5828. PubMed ID: 27307593
[TBL] [Abstract][Full Text] [Related]
7. bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain Injury.
Wang ZG; Cheng Y; Yu XC; Ye LB; Xia QH; Johnson NR; Wei X; Chen DQ; Cao G; Fu XB; Li XK; Zhang HY; Xiao J
Mol Neurobiol; 2016 Dec; 53(10):7298-7311. PubMed ID: 26687235
[TBL] [Abstract][Full Text] [Related]
8. VEGF regulates PCB 104-mediated stimulation of permeability and transmigration of breast cancer cells in human microvascular endothelial cells.
Eum SY; Lee YW; Hennig B; Toborek M
Exp Cell Res; 2004 Jun; 296(2):231-44. PubMed ID: 15149853
[TBL] [Abstract][Full Text] [Related]
9. Involvement of phospholipase C signaling in melanoma cell-induced endothelial junction disassembly.
Peng HH; Hodgson L; Henderson AJ; Dong C
Front Biosci; 2005 May; 10():1597-606. PubMed ID: 15769649
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models.
Choi YP; Lee JH; Gao MQ; Kim BG; Kang S; Kim SH; Cho NH
Int J Cancer; 2014 Nov; 135(9):2024-33. PubMed ID: 24643985
[TBL] [Abstract][Full Text] [Related]
11. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury.
Zheng B; Ye L; Zhou Y; Zhu S; Wang Q; Shi H; Chen D; Wei X; Wang Z; Li X; Xiao J; Xu H; Zhang H
J Cell Mol Med; 2016 Jun; 20(6):1062-75. PubMed ID: 26769343
[TBL] [Abstract][Full Text] [Related]
13. VE-cadherin-independent cancer cell incorporation into the vascular endothelium precedes transmigration.
Hamilla SM; Stroka KM; Aranda-Espinoza H
PLoS One; 2014; 9(10):e109748. PubMed ID: 25275457
[TBL] [Abstract][Full Text] [Related]
14. RacGAP1-driven focal adhesion formation promotes melanoma transendothelial migration through mediating adherens junction disassembly.
Zhang P; Bai H; Fu C; Chen F; Zeng P; Wu C; Ye Q; Dong C; Song Y; Song E
Biochem Biophys Res Commun; 2015 Mar; 459(1):1-9. PubMed ID: 25475728
[TBL] [Abstract][Full Text] [Related]
15. Cancer cells regulate biomechanical properties of human microvascular endothelial cells.
Mierke CT
J Biol Chem; 2011 Nov; 286(46):40025-37. PubMed ID: 21940631
[TBL] [Abstract][Full Text] [Related]
16. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.
Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A
Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.
Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K
Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023
[TBL] [Abstract][Full Text] [Related]
18. Insulin stabilizes microvascular endothelial barrier function via phosphatidylinositol 3-kinase/Akt-mediated Rac1 activation.
Gündüz D; Thom J; Hussain I; Lopez D; Härtel FV; Erdogan A; Grebe M; Sedding D; Piper HM; Tillmanns H; Noll T; Aslam M
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1237-45. PubMed ID: 20339116
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer.
Hampsch RA; Shee K; Bates D; Lewis LD; Désiré L; Leblond B; Demidenko E; Stefan K; Huang YH; Miller TW
Oncotarget; 2017 Mar; 8(13):21806-21817. PubMed ID: 28423521
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.
Wang Y; Kunit T; Ciotkowska A; Rutz B; Schreiber A; Strittmatter F; Waidelich R; Liu C; Stief CG; Gratzke C; Hennenberg M
Br J Pharmacol; 2015 Jun; 172(11):2905-17. PubMed ID: 25631101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
